Takeda Pharmaceutical TAK
NYSE TAK
$17.87 -0.32 (-1.76%)
As of: Oct 1, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Intangibles (2017 - 2026)

Updated

Takeda Pharmaceutical's Intangibles was $21.28 billion in the quarter ended Jun 30, 2026, down 10.1% from $23.65 billion a year earlier and down 2.4% from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) Intangibles (2017 - 2026) Analysis & Trends

As of Mar 31, 2026, Intangibles at Takeda Pharmaceutical came in at $22.72 billion, down 4.7% from the prior year.

  • Intangibles has now declined for seven consecutive years, with a five-year compound annual growth rate of -9.2% (years ended Mar 2021 to Mar 2026).
  • In earlier years, Intangibles was $23.84 billion in the year ended Mar 31, 2025 (-19.6%), $29.64 billion in the year ended Mar 31, 2024 (-6.2%), $31.61 billion in the year ended Mar 31, 2023 (-7.1%) and $34.01 billion in the year ended Mar 31, 2022 (-7.8%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Intangibles since the quarter ended Dec 31, 2018.
  • Compared with a year earlier, Intangibles has declined for ten straight quarters, with an average decline of 12.3% over the last eight quarters.
  • The best year-over-year quarter for Intangibles over five years was the quarter ended Dec 31, 2023 (growth of 4.0%); the worst was the quarter ended Mar 31, 2025 (a decline of 17.5%).
  • Per Business Quant data, TAK's Intangibles in the three quarters before the quarter ended Jun 30, 2026 was $21.8 billion (quarter ended Mar 31, 2026), $22.84 billion (quarter ended Dec 31, 2025) and $22.39 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 48.23 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.14 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 42.07 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 37.72 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 20.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 14.03 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 47.05 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 412.80 Mn
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn 21.28 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.28 Bn
Mar 31, 2026 21.80 Bn
Dec 31, 2025 22.84 Bn
Sep 30, 2025 22.39 Bn
Jun 30, 2025 23.65 Bn
Mar 31, 2025 23.80 Bn
Dec 31, 2024 26.00 Bn
Sep 30, 2024 25.28 Bn
Jun 30, 2024 28.05 Bn
Mar 31, 2024 28.84 Bn
Dec 31, 2023 27.72 Bn
Sep 30, 2023 30.48 Bn
Jun 30, 2023 32.94 Bn
Mar 31, 2023 32.28 Bn
Dec 31, 2022 26.66 Bn
Sep 30, 2022 30.32 Bn
Jun 30, 2022 32.05 Bn
Mar 31, 2022 32.86 Bn
Jun 30, 2021 35.23 Bn
Mar 31, 2021 36.93 Bn
API Access

Takeda Pharmaceutical Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=TAK&period=max&api_key=YOUR_API_KEY